4.4 Review

Platelet-derived microvesicles (PMVs) in cancer progression and clinical applications

Journal

CLINICAL & TRANSLATIONAL ONCOLOGY
Volume 25, Issue 4, Pages 873-881

Publisher

SPRINGER INT PUBL AG
DOI: 10.1007/s12094-022-03014-3

Keywords

Platelet; Cancer therapy; Microvesicles; PMV; Cancer

Categories

Ask authors/readers for more resources

Platelet-derived microvesicles (PMVs) play a crucial role in cancer by interacting with cancer cells and nontransformed cells in the tumor microenvironment, transferring platelet-derived contents, and influencing the response of target cells.
Platelet-derived microvesicles (PMVs), the microvesicles with the highest concentration in the bloodstream, play a key role in the regulation of hemostasis, inflammation, and angiogenesis. PMVs have recently been identified as key factors in the link between platelets and cancer. PMVs bind to both cancer cells and nontransformed cells in the microenvironment of the tumor, and then transfer platelet-derived contents to the target cell. These contents have the potential to either stimulate or modulate the target cell's response. PMVs are encased in a lipid bilayer that contains surface proteins and lipids as well as components found inside the PMV. Each of these components participates in known and potential PMV roles in cancer. The complicated roles played by PMVs in the onset, development, and progression of cancer and cancer-related comorbidities are summarized in this study.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available